ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Huatanmaitong tablet alleviate cerebral ischemic reperfusion injury with hyperlipidaemia in rats by regulating OATPs/VEGF axis

Sun, Shuangxi; Wang, Qi; Chen, Hongxia; Pan, Ruihuan*广州中医药大学
Cellular and Molecular Biology2023DOI: 10.14715/cmb/2023.69.13.35
5阅读
引用收藏
分享

摘要

Stroke is the top priority pathogenesis of disability and death globally, affecting people worldwide. The presence of high levels of lipids in the blood has been confirmed as a vital factor of ischemic stroke. We aim to examine the effectiveness of Huatanmaitong tablet in hyperlipidemia rats that have experienced an ischemic stroke. We created a rat model of middle cerebral artery occlusion (MCAO) with hyperlipidemia as a basis. Following 8 weeks of high-fat diet, the model rats underwent MCAO surgery. Subsequently, the rats were administered huatanmaitong tablets and lipitor tablets as treatments. Therefore there are five groups, CONTROL, MCAO, hyperlipidemia (HLP), Huatanmaitong tablet (HTMTT) and Lipitor (LIPITOR) groups respectively. To assess the efficacy of the medication, the serum lipid levels of rats were measured both prior to and following administration. Hematoxylin eosin staining was used to observe the alterations in the brain and liver structures within each group. VEGF and OATPs-related factors were detected in brain, and liver by using immunohistochemistry, Western blotting, and Quantitative PCR. After the model was established successfully, the infarct volume and behavioral scores of the model group, hyperlipidemia group, Huatan Maitong tablet group and Lipitor group had statistical differences (P<0.05). Blood lipid levels of rats were measured before and after treatment, and it was found that Huatanmaitong tablets effectively reduced these levels. Hematoxylin and eosin staining of the brain and liver showed that huatanmaitong tablets maintained the microstructure stability. Western blotting and real-time PCR revealed that Huatanmaitong tablets improved the expression level of organic anion transport (OATP1B1, OATP2B1) in rat tissues with ischemic stroke, enhancing the transmembrane transport of exogenous substances and maintaining homeostatic balance. Additionally, it downregulated the expression of VEGF in various organs such as the brain, and liver, demonstrating the ability of Huatanmaitong tablets to remove phlegm, blood stasis, and promote circulation by regulating serum lipid levels, organic anion transport peptide, and VEGF in rats. The behavioral score of ischemic stroke rats can be improved and the neurological impairment symptoms of rats can be alleviated by Huatanmaitong tablet through the regulation of OATPS/VEGF axis.

学科与关键词

关键词
Huatanmaitong tabletshyperlipidemiaMCAOatorvastatin calcium
相关
加载中…
  • Chuanzhitongluo capsule ameliorates microcirculatory dysfunction in rats: Efficacy evaluation and metabolic profiles
    Sun, Yuanfang; Cheng, Guoliang; Du, Lijing; Gan, Yu; Li, Bing; Yan, Shikai; Shao, Mingguo*; Jin, Huizi; Li, Shasha*Frontiers in Pharmacology, 2022, 13: 1011333.被引 4
  • Tongxinluo Enhances Neurogenesis and Angiogenesis in Peri-Infarct Area and Subventricular Zone and Promotes Functional Recovery after Focal Cerebral Ischemic Infarction in Hypertensive Rats
    Chen Li; Wang Xiaoting; Zhang Jian; Dang Chao; Liu Gang; Liang Zhijian; Huang Gelun; Zhao Weijia; Zeng Jinsheng*Evidence-based Complementary and Alternative Medicine, 2016, 8549590.
  • Tongxinluo attenuates neuronal loss and enhances neurogenesis and angiogenesis in the ipsilateral thalamus and improves neurological outcome after focal cortical infarction in hypertensive rats
    Chen Li; Wang Xiaoting; Chen Xinran; Xing Shihui; Zhang Jian; Li Jingjing; Dang Chao; Liu Gang; Dang Ge; Zeng Jinsheng*Restorative Neurology and Neuroscience, 2014, 32(4): 533-546.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Cellular and Molecular Biology
发表日期
2023
卷期
第 69 卷, 第 13 期
页码
235-240
DOI
10.14715/cmb/2023.69.13.35
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
Guangdong Provincial Key Laboratory of Chinese Medicine for the Prevention and Treatment of Difficult Chronic Diseases [2018B030322012]; NATCM's Project of High-level Construction of Key TCM Disciplines [zyyzdxk-2023154]; Shen Baofan's Academic Experience Inheritance Studio; Guangdong Provincial Hospital of Chinese Medicine (Second Hospital of Chinese Medicine) [2018-101]; CUHK School of Biomedical Sciences-Guangdong Provincial Hospital of Traditional Chinese Medicine Translational Collaborative Innovation Scheme [YN2018HK03]

作者

  • S

    Sun, Shuangxi (第一作者)

    2 · guangzhou univ chinese med

  • W

    Wang, Qi

    guangzhou univ chinese med

查看全部 4 位作者收起作者
  • C

    Chen, Hongxia

    2 · guangzhou univ chinese med

  • P

    Pan, Ruihuan (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417